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Abstract
Background: Restriction endonucleases are widely applied in recombinant DNA technology. Among them,
enzymes of class IIS, which cleave DNA beyond recognition sites, are especially useful. We use BsaI enzyme for the
pinpoint introduction of halogen nucleobases into DNA. This has been done for the purpose of anticancer radio-
and phototherapy that is our long-term objective.
Results: An enzymatic method for synthesizing long double-stranded DNA labeled with the halogen derivatives of
nucleobases (Hal-NBs) with 1-bp accuracy has been put forward and successfully tested on three different DNA
fragments containing the 5-bromouracil (5-BrU) residue. The protocol assumes enzymatic cleavage of two
Polymerase-Chain-Reaction (PCR) fragments containing two recognition sequences for the same or different class
IIS restriction endonucleases, where each PCR fragment has a partially complementary cleavage site. These sites are
introduced using synthetic DNA primers or are naturally present in the sequence used. The cleavage sites are not
compatible, and therefore not susceptible to ligation until they are partially filled with a Hal-NB or original
nucleobase, resulting in complementary cohesive end formation. Ligation of these fragments ultimately leads to
the required Hal-NB-labeled DNA duplex. With this approach, a synthetic, extremely long DNA fragment can be
obtained by means of a multiple assembly reaction (n × maximum PCR product length: n × app. 50 kb).
Conclusions: The long, precisely labeled DNA duplexes obtained behave in very much the same manner as
natural DNA and are beyond the range of chemical synthesis. Moreover, the conditions of synthesis closely
resemble the natural ones, and all the artifacts accompanying the chemical synthesis of DNA are thus eliminated.
The approach proposed seems to be completely general and could be used to label DNA at multiple pre-
determined sites and with halogen derivatives of any nucleobase. Access to DNAs labeled with Hal-NBs at specific
position is an indispensable condition for the understanding and optimization of DNA photo- and radio-
degradation, which are prerequisites for clinical trials of Hal-NBs in anticancer therapy.
Background
Class IIS restriction endonucleases (REases) are widely
applied in recombinant DNA technology. In a series of
pioneer studies, Szybalski et al. [1] showed that class-IIS
REases offer novel possibilities for DNA manipulation,
for example, a “universal restriction endonuclease”,
cleaving a pre-determined sequence in single-stranded
DNA with the assistance, inter alia,o fh a i r p i n
oligodeoxyribonucleotides (oligo) [2,3], Achilles’ Heel
Cleavage of DNA [4,5], a DNA fragment amplification
vector [6], and chimeric repressor-REase enzymes [7].
Here we use class IIS enzymes to precisely incorporate
modified nucleobases into DNA in order to enhance its
photo- and radiosensitivity.
Substituting a hydrogen atom of a nucleic base (NB)
with a halogen atom leads to a minor change in the NB
structure. As a result, DNA containing halogen-substi-
tuted nucleobases (Hal-NBs) possesses the same struc-
tural features as the native biopolymer. Owing to the
photo- and radiosensitivityo fH a l - N B ,h o w e v e r ,s u c h
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ionizing radiation and more sensitive to UV light.
Therefore, halogen-substituted uracils (5-XU) have been
used in the past as structural probes of the nucleic acid
structure [8-10] and for mapping protein-nucleic acid
interactions [11-14]. 5-bromouracil (5-BrU) has also
been employed in studies of long-distance electron
transfer in DNA [15]. The attachment of an electron to
5-BrU triggers the quantitative release of bromide
anions and uracil, a process that is easily evaluated.
Since the number of 5-BrU/electron reactions can be
monitored, the maximum average electron migration
distance along the helix can be estimated [16]. Recently,
Cecchini et al. [17] demonstrated that the irradiation of
double-stranded DNA containing 5-BrU with ionizing
radiation leads to interstrand cross-links, one of the
most toxic types of DNA damage. The toxicity of DNA
cross-links is probably the result of two mechanisms:
one prevents strand separation, thus inhibiting both
transcription and replication, the other can induce
mutations and DNA rearrangements as a result of the
repair process [17]. It has also been shown that irradia-
tion of 5-bromocytosine (5-BrC) [18-20] labeled DNA
with near-UV light brings about intrastrand photo-
cross-linking: adducts are formed photochemically
between 5-BrC and adjacent nucleobases.
Incorporation of 5-BrU in DNA increases the biopoly-
mer’s susceptibility to single- and double-strand break-
age induced by ionizing radiation [21] and influences
the rate of DNA repair of potentially lethal damage [22].
Among the main products of water radiolysis are low-
energy electrons that can attach to bromouracil [17].
The unstable bromouracil anion is stabilized when the
bromine anion is detached, which causes the very reac-
tive uracil-5-yl radical to form. This species can attack
the C2’ and C1’ centers of the adjacent 2-deoxyribose,
thereby inducing DNA strand cleavage. It is also
assumed that the same uridyl radical forms as a result
of interaction between UV-radiation and DNA labeled
with 5-bromouracil [23,27]. The preliminary steps of the
photochemical process are probably related to photo-
induced electron transfer between electronically excited
5-bromouracil and the adjacent nucleobase [25,26]. This
conclusion was suggested by the experimentally
observed strong dependence of the extent of damage on
the base sequence [27-29].
Since the structural changes associated with the incor-
poration of a halogen atom into a nucleic acid base are
only minor, nucleotides containing Hal-NBs can be used
by a cell for DNA biosynthesis (the cellular enzymatic
system does not radically differentiate between Hal-NBs
and natural nucleotides) [30]. Furthermore, the incor-
poration of Hal-NBs in DNA sensitizes the biopolymer to
UV and ionizing radiation. It seems, therefore, that Hal-
NBs could be employed in the therapy of cancer diseases.
It has already been reported that 5-BrU increases the
likelihood of cells being damaged by ionizing radiation
[31]. The enhanced response of non-hypoxic tumor cells
to radiation in the presence of bromodeoxyuridine, iodo-
deoxyuridine and fluorodeoxyuridine has been recog-
nized in several clinical trials [32-34]. Some clinical
studies have also reported the radiosensitization of malig-
nant brain tumors by bromodeoxyuridine [35].
With such properties, Hal-NBs are potentially potent
anticancer drugs in radio- and phototherapy. However,
without an understanding of the molecular mechanisms
leading to DNA breakage their rational use is not possi-
ble. Hence, before these substances can be implemented
in clinical practice, comprehensive, multidisciplinary stu-
dies need to be carried out in order to elucidate the
consecutive stages of the process leading to DNA
damage induced by UV light or an excess electron.
If the photo- and radiochemical studies aiming at the
understanding and optimization of DNA degradation
process are to yield reliable results, we need access to
DNA fragments of pre-defined sequences labeled with
Hal-NBs at precisely determined positions. Furthermore,
relatively short double-stranded DNA (from tens to
hundreds of base pairs) is known to behave more like a
“rigid rod” [36]. On the other hand, DNA molecules in
vivo achieve lengths of from several thousand to hun-
dreds of millions of base pairs. Hence, short synthetic
DNA fragments seem to be quite a crude model of nat-
ural DNA, since the effects due to folding (e.g. super-
coiled DNA) could profoundly affect the susceptibility
to damage of the biopolymer’s chemical bonds. So far,
all studies of damage to Hal-NB-labeled DNA have
focused on short oligo fragments - 30-40 base-pairs (bp)
at the most. In this work we describe a new technique
of DNA labeling for synthesizing DNA fragments of up
to several hundred base pairs. This target has been
achieved by employing the site-directed introduction of
nucleotide derivatives into dsDNA molecules with the
use of a multi-enzymatic complex. Such long DNA
duplexes behave in a manner similar to that of natural
DNA and are beyond the range of efficient chemical
synthesis. Moreover, bacterial thermostable polymerases
are employed in DNA synthesis; consequently, the con-
ditions of DNA synthesis closely resemble the natural
ones, and artifacts accompanying chemical synthesis
(impurities resulting from side-products, uncontrolled
modifications, heterogeneity of DNA length, etc.) are
thus eliminated. Although the nature of these trace con-
taminants has not been evaluated, gene cloning scien-
tists are well aware that synthetic DNA tends to cause
far greater problems in enzymatic manipulation than
DNA obtained from a native source or in a PCR reac-
tion. This also applies to ligation efficiency.
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cially designed to prepare long DNA duplexes labeled
with Hal-NBs.
Results and discussion
General idea
The incorporation of one or two molecules of 5-BrdU
per molecule of synthetic duplex taking place in the
above-mentioned process is illustrated schematically in
Figure 1. Let us assume that two double-stranded DNA
fragments (I-T and III-Br, Figure 1C) possessing 3-nt
complementary sticky ends are available. One of these
fragments (III-Br) contains 5-BrdU instead of thymidine
i nt h eb a s ep a i rp r e c e d i n gt h ec o h e s i v ee n d .A f t e rt h e
ligation of I-Br with III-T, the final product is synthe-
sized, i.e. double-stranded DNA internally labeled with
5-BrdU. I-T and III-Br can be obtained from fragments
I and III (Figure 1C) using a DNA polymerase and
dTTP or BrdUTP, respectively. The first base of the
initially non-complementary 4-nt cohesive ends of frag-
ments I and III has to be adenine if a DNA fragment
labeled with 5-BrdU is to be synthesized. The filling of
the non-complementary strand with thymidine or 5-bro-
mouridine (single- or double labeling of both strands)
produces two complementary, 3-nt sticky ends. If, for
instance, the 5’-YYY sequence (the lower strand of the
final product) appears at the cohesive end of III-Br,t h e
5’-XXX sequence (the upper strand of the final product)
has to be generated in I-T, where X and Y are the com-
plementary bases. Thus, the 4-nt cohesive ends gener-
ated by a class-IIS REase cannot be cross-ligated
between duplexes I and III unless the first base of the
4-nt cohesive end is filled with dTTP (or BrdUTP) (Fig-
ure 1D).
So, in order to obtain a DNA fragment with 5-BrdU
incorporated into it, two double stranded duplexes
( P C R 1a n dP C R 2 ,F i g u r e1 A B )h a v et ob es y n t h e s i z e d
with appropriately located terminal sites sensitive to
class-IIS REases. These duplexes are then used to gener-
a t es u b - d u p l e x e sb yB s a Id i g estion, yielding four frag-
ments: I, II, III, and IV. Filling duplexes I and III with
BrdUTP (resulting in I-Br and III-Br, Figure 1C) yields
an internally double labeled DNA molecule containing
two BrdU residues separated by 3 bp.
In principle, the same or different class-IIS REases,
producing 5’ protruding 4-nt cohesive ends, could be
used for the cleavage of PCR1 and PCR2. After minor
modification, also other class-IIS REases producing 5’
protruding cohesive ends of the length 2-nt or longer
can be used. The choice of class-IIS REase used will also
be dictated by the preferred absence of its cognate site
within the DNA segment to be amplified as well as by
its desired enzymatic parameters. However, the presence
of the same class-IIS site within the DNA molecule does
not preclude application of the method. Statistically only
1 in 256 4-nt cohesive ends in the cleavage site will be
identical. Because of the uniqueness of cohesive ends
generated by class-IIS REases, only intended hybrid
molecules should be assembled. However, if the cohesive
ends have consecutive adenines (Figure 2; in the seventh
(X) and ninth (Y) position) resulting ends will not be
able to ligate after filing them with BrdUTP. In case of a
singly labeled DNA, on average 1 in 4 of 4-bp cleavage
sites sequences will block the assembly reaction. Hence,
for the 6-bp class IIS REase recognition site (on average
one every 4096 bp), flanked by 4-bp cleavage site, the
maximum length of the final labeled molecule is limited
to the assembly of 3 permissive combinations (C, G or
T in the crucial position). Thus the maximum length of
the labeled DNA molecule amounts to 4096 × 3 = 12
288 bp. In order to overcome limitation imposed by the
presence of the internal recognition sites one may select
those REases, which recognize longer DNA sequences.
For example, SapI REase recognizes 7-bp sequence:
GCTCTTC(N1/4), thus cleaving on average every 16
384 bp [37]. Another solution of the problem could be
the 2-step methylation method for extension of a recog-
nition site of a class-IIS REases [38].
There are two alternative modes of assembling hybrid
DNA molecules. In the first mode, native sequence
hybrid DNA molecules are generated when class-IIS
sites are oriented toward the 3’ ends of the primers used
and are adjacent to the beginning of the original, native
sequence to be re-joined. 5’ portions of the primers
along with the class-IIS sites are cut off during the pro-
cedure, leaving only 4-nt cohesive ends, which are part
of the original DNA template (Figure 2). When the nat-
ural sequences are to be labeled, they must be in the
form of 5’-TXXXN-3’, where the first X cannot be T
and N cannot be identical to the last X (in the single
position labeling variant) or the sequence must be in
the form of 5’-TXXXA-3’, where the first X cannot be T
and the last X cannot be A (in the double position label-
ing variant). The bases in the 7-9 positions (marked as
Xs) do not have to be identical (Figure 2A). It is impor-
tant to remember during primers design, that incorpo-
rated class-IIS REase sites need to be properly
positioned, e.g. offset by one base in the two primers to
give 5’-XXXA (or 5’-XXXN for single labeling variant)
and 5’- Y Y Y Ao v e r h a n g s ,t oa v o i di n c o r p o r a t i o no fa n
additional base into the native sequence (Figure 2D).
The second mode is based on either the 5’-o rt h e3 ’-
orientation of the class-IIS REase sites, where additional
sequences are incorporated from the primers used (with
or without the class-IIS sites used) (Figure 1). Should
additional sequences be incorporated, the procedure will
result in internally labeledm u t a n th y b r i dm o l e c u l e s .
The potential applicability extends beyond an
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can be used to study protein-DNA interaction by, for
example, the precise incorporation of modified bases
into the DNA-interacting protein recognition sites pre-
sent on long DNA molecules.
Design of hybrid, BrdU-labeled DNA molecules with the
use of BsaI REase
A specific class-IIS enzyme BsaI recognizes 5’-
GGTCTC-3’ DNA sequence and cleaves downstream at
1 nt (top strand) and 5 nt (bottom strand) at any
Figure 1 Diagram of single- and double-label incorporation with pinpoint precision internally within long DNA molecules.B r - U
symbolizes incorporated 5-bromodeoxiuridine; N symbolizes unspecified nucleotides. * complementarity between the three bases within the
overhang (XXX/YYY) is necessary
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selected for this study as it recognizes DNA relatively
infrequently - on average every 4096 bp, cleaves DNA
to completion and is a robust thermophilic enzyme.
Processing duplexes with the enzyme generates two
fragments, I and II, for the first duplex (PCR 1), and
two fragments, III and IV, for the second one (PCR 2)
(Figure 1 AB). Since both double-stranded duplexes pos-
sess the class-IIS REase (BsaI) site, the tetranucleotide
“sticky” ends produced by BsaI cleavage can be pre-pro-
grammed to have any sequence. The sequence of the
cohesive ends has been devised in such a way that the
first base, immediately adjacent to the double stranded
portion of the DNA fragment (thus closest to the class-
IIS BsaI recognition site), is the same for both the first
and the second duplex (in the case of BrdU incorpora-
tion, it is the complementary base A), whereas the fol-
lowing 3-nt are reverse complements: 5’-GGG and 5’-
CCC. Thus, the cohesive ends generated by BsaI are 5’-
GGGA and 5’-TCCC for duplex 1, and 5’-CCCA and 5’-
TGGG for duplex 2. Hence, the cohesive ends generated
cannot be cross-ligated between duplexes 1 and 2 unless
the first base of the 4-nt cohesive end is filled with
dTTP (or BrdUTP), generating complementary 5’-CCC
and 5’-GGG single stranded DNA sequences (Figure
1C). Cleaved PCR fragments not filled with BrU are
Figure 2 Diagram of internally labeled native-sequence hybrid DNA molecule generation. To obtain a labeled native DNA sequence the
following sequence requirements must be fulfilled: * in the seventh (X) and/or ninth position (Y) a non-A nucleotide is required depending on
the labeling mode. * complementarity between the three bases within the overhang (positions 7-9; XXX/YYY) is necessary. * A/T in the tenth
position is not required for a single DNA labeling. Br-U symbolizes incorporated 5-bromodeoxiuridine; N symbolizes unspecified nucleotides
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compatible cohesive ends are produced. Thus, to acti-
vate the final step, the missing thymidine in fragment III
needs to be complemented with BrdU and the missing
thymidine (or BrdU for the purpose of double labeling)
in fragment I. Ligation of fragments I and III produces
the new double stranded duplex, containing one or two
precisely incorporated internal BrdU residues (Figure
1D). In general, the procedure can be extended, so that
in one production cycle duplexes can be prepared with
several different specific sequences cleaved by different
enzymes, incorporating a label at more than one pre-
defined location or incorporating different labels in the
same DNA molecule. We chose 5’-CCC/5’-GGG cohe-
sive ends to increase annealing, and therefore to achieve
more efficient ligation. Nevertheless, the method is uni-
versally applicable to any asymmetric cohesive ends, as
long as complementarity is generated upon partial fill-
ing. The mutations accumulating in the PCR step of
preparing DNA to be modified may constitute a limita-
tion to the method if an excessive number of cycles is
being used. It would therefore be beneficial to optimize
every labeling reaction at the initial PCR stage as well,
in order to minimize the effective number of cycles
needed. The polymerase used imposes a limitation on a
modified nucleotide incorporated into DNA. Every poly-
merase/label combination therefore needs to be verified
experimentally.
Assessing various DNA polymerases and assembly
reaction conditions for the ability to incorporate BrdU
The method described here was used as a model for
further anti-cancer therapy studies; it was not limited to
the use of BrdUTP as a cytotoxic compound when
incorporated into DNA. It is expected that the different
labels present in modified dNTPs will be utilized with
various affinities by DNA Polymerases, thus resulting in
incorporation into DNA with greatly varying efficiency.
Reaction limitations may also arise from the substrate
requirements of DNA Ligase. Figure 3 shows labeling
reactions performed under demanding conditions - dou-
ble BrdU residues incorporated in close proximity using
various DNA polymerases. The conditions of double
labeling were chosen to determine whether DNA Ligase
Figure 3 Assessment of various DNA polymerases for their ability to incorporate BrdU. Complete and incomplete specific incorporation
reactions (Figure 1) were carried out with 5 DNA Polymerases: Bst exo
- (thermophilic), T4 (mesophilic), Taq (thermophilic), OptiTaq (thermophilic
blend) and Pfu (hyperthermophilic) in the presence of BrdUTP. Lanes M, Perfect 100 bp Ladder; lane 1, PCR 1 fragment (379 bp); lane 2, BsaI-
cleaved PCR 1 fragment; lane 3, PCR 2 fragment (625 bp); lane 4, BsaI-cleaved PCR 2 fragment; lane 5, BsaI restriction fragments: I (363 bp) and III
(609 bp). Lanes 6-18 reactions with specified DNA Polymerases: lane 6, restriction fragments: I and III, T4; lane 7, restriction fragments: I and III, Bst
exo
- ; lane 8, restriction fragments: I and III, Bst exo
- , T4 DNA Ligase; lane 9, restriction fragments: I and III, T4; lane 10, restriction fragments: I
and III, T4, T4 DNA Ligase; lane 11, restriction fragments: I and III, Taq; lane 12, restriction fragments: I and III, Taq, T4 DNA Ligase; lane 13,
restriction fragments: I and III, OptiTaq; lane 14, restriction fragments: I and III, OptiTaq, T4 DNA Ligase; lane 15, restriction fragments: I and III, Tfl;
lane 16, restriction fragments: I and III, Tfl, T4 DNA Ligase; lane 17, restriction fragments: I and III, Pfu; lane 18, restriction fragments: I and III, Pfu,
T4 DNA Ligase.
I, III BsaI restriction fragments numbered as in Figure 1.
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ing unnatural bases within strand nicks, just 3 bp apart.
Clearly, DNA Ligase can utilize such unusual substrates.
Moreover, we explored the possibility of increasing label
density in DNA for the purpose of future studies of the
enhanced sensitization of DNA and stimulation of dou-
ble strand breakage following irradiation of neighboring
BrdU residues in DNA: after incorporation, the modified
Hal-modified residues are separated by only 3 bp.
The evaluation of polymerases shows clearly that the
Bacillus stearothermophilus DNA Polymerase exo
- C-
terminal fragment exhibits the highest final yield of the
generation hybrid 977 bp DNA molecule (Figure 3, lane
8), while the mesophilic T4 bacteriophage DNA Poly-
merase, Thermus aquaticus DNA Polymerase, proof-
reading Taq-Pfu blend DNA Polymerase (OptiTaq) and
Thermus flavus DNA Polymerase exhibit a markedly
lower reaction yield (Figure 3, lanes 10, 12, 14, 16). Pyr-
ococcus furiosus proofreading DNA Polymerase does not
result in any incorporation of BrdU; indeed, substantial
DNA losses are observed (Figure 3, lane 18). The reac-
tion is assayed for the presence of the final product,
namely, the desired 977 bp band, and factors other than
the ability to utilize BrdUTP are likely to play a role in
the final yield. This may involve maintaining the integ-
rity of 3-nt 5’-protruding DNA termini, owing to a lack
of proofreading activities in the case of of Taq, Tfl and
T4 polymerases. In view of the emergence of new ther-
mostable polymerases, either discovered in nature or
protein-engineered, further improvements of the method
presented here are possible. Among the commercially
available DNA polymerases a mutant of Pfu DNA poly-
merase that overcomes uracil stalling, allowing the poly-
merase to read through uracil located in the template
strand or incorporated into the extending strand could
be worth trying [39]. To further evaluate the universality
of the method beyond just a single combination of frag-
ments yielding a hybrid molecule, which increases the
concentration of the label/per DNA molecule unit
length for the purpose of HPLC analysis, additional 441
bp and 466 bp hybrid molecules were designed and con-
structed. The 441 bp fragment was synthesized in the
single BrdU residue integration mode and also in the
double BrdU incorporation mode using Bst exo
- DNA
Polymerase (Figure 4). There was no difference in yield,
regardless of whether double BrdU or single BrdU/single
T residues were incorporated with a one bp precision
(Figure 4, lane 3, 5). These results were confirmed with
the construction of the 466 bp hybrid molecule (Figure
5, lane 9, 10). The reaction was closely monitored by
the inclusion of a set of controls at key steps of the
incorporation/assembly reaction (Figures 3, 4, 5). As a
result of the use of non-phosphorylated primers and
asymmetric cohesive ends, the synthesis reactions
depicted in Figures 3, 4 and 5 gave yields of the labeled
molecules of over 50% with no by-products.
In order to simplify the analysis of labeled species, we
have used 441, 466 and 977 bp model hybrid molecules.
However, one should keep in mind, that the upper limit
of labeled molecules length is much higher. With this
method, extremely long DNA fragment can be obtained
by means of a multiple assembly reaction (n × maxi-
mum PCR product length: n × app. 50 kb).
The method presented therefore seems to be uniquely
suited to the construction of models for in vitro studies
of anti-cancer therapy properties. Moreover, the method
can be extended to protein-DNA interaction studies, by
for example, the precise incorporation of modified bases
into DNA-interacting protein recognition sites present
on long DNA molecules.
Determination of the presence of BrdU in hybrid DNA
molecule
The occurrence of bands corresponding to the BrdU-
labeled hybrid DNA molecules in the gels (Figures 3, 4,
and 5) is indirect proof that BrdU is incorporated into
the ultimate product. Indeed, if the cohesive ends gener-
ated by BsaI are not filled with BrdUTP (or dTTP), no
final product is obtained. However, when the partial fill-
ing of the cohesive ends precedes ligation, the formation
Figure 4 Incorporation of double and single BrdU residues by
Bst exo
- DNA Polymerase into the 441 bp hybrid molecule.
Incorporation reactions using BrdUTP alone or in combination with
dTTP were carried out with Bst exo
- DNA Polymerase. Lanes M,
Perfect 100 bp Ladder (selected bands marked); lane 1, 260 bp BsaI-
cleaved PCR (restriction fragment I); lane 2, 208 bp BsaI-cleaved PCR
(restriction fragment III); lane 3, BrdUTP-filled restriction fragments I
and III, T4 DNA ligase; lane 4, BrdUTP-filled restriction fragments I
and III; lane 5, dTTP-filled restriction fragment I and BrdUTP-filled
restriction fragment III, T4 DNA ligase; lane 6, dTTP-filled restriction
fragment I and BrdU-filled restriction fragment III. Lanes 7-9, controls
of enzymes functional purity: lane 7, control PCR fragment with
internal BsaI site; lane 8, BsaI-cleaved control PCR fragment; lane 9,
BsaI-cleaved control PCR fragment after addition of T4 DNA Ligase;
lane M, Perfect 100 bp Ladder.
I, III BsaI restriction fragments
numbered as in Figure 1.
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Figure 4, lanes 3, 5; Figure 5, lanes 9, 10). Thus, one can
infer that if the cohesive ends are partially filled with
BrdUTP, BrdU has to be present in a hybrid DNA mole-
cule. Although this indirect reasoning sounds convin-
cing, one can also demonstrate directly that the BrdU
molecule is present in the ligation product: namely,
HPLC coupled to DNA digestion down to nucleosides is
a suitable method for directly demonstrating the pre-
sence of BrdU in the synthesized material. Since the
sensitivity of HPLC detection depends on the amount of
a substance in the assayed sample, we chose the shortest
fragment (of the three synthesized) labeled with two
BrdU molecules to demonstrate the presence of 5-bro-
mouridine. As a result of this choice we analyzed a
digestion mixture in which the ratio of BrdU to the
remaining nucleosides was the highest possible (taking
into account the fact that three DNA fragments differing
in the length and number of BrdU molecules were
synthesized). Figure 6 shows two chromatograms: the
upper panel (Figure 6A) corresponds to the HPLC
separation of a mixture containing native nucleosides
and 5-bromouridine; the lower panel (Figure 6B) shows
the chromatogram obtained for the digested 441 bp
fragment containing two molecules of BrdU. The peak
with the retention time of 26.9 min (Figure 6B) corre-
sponds well to the BrdU signal (27.1 min) in the chro-
matogram of standards (Figure 6A). The small peak (see
the absorbance scale) at 29.2 min, as well as the peaks
before the dC peak, between the dC and dA, dA and dG
and dG and dT peaks, are due to the digestion proce-
dure, as indicated by the chromatogram obtained for the
441 bp fragment, which does not contain the BrdU
molecules (not shown). Additionally, by employing the
peak areas of standards and the areas of the actual sig-
nals registered for the digested 441 bp labeled oligonu-
cleotide, we were able to calculate its base content: the
amount of BrdU turned out to be equal to 1.93, which
is quite close to the theoretical value of 2. HPLC separa-
tion coupled to enzymatic digestion therefore demon-
strates unequivocally that an oligonucleotide containing
BrdU is indeed produced within our protocol.
Conclusions
i. A new method of incorporating labeled nucleo-
tides at a precisely-predetermined location has been
developed.
ii. The length of these enzymatically synthesized
DNA molecules theoretically approaches a multiple
of the maximum length obtainable in a single PCR
reaction.
iii. The synthesis efficiency of the labeled molecules
is better than 50% with no by-products
iv. This method is general and offers the possibility
of preparing DNA duplexes labeled with a controlled
number of Hal-Nbs as well as other labels.
v. A number of DNA polymerases have been tested
for the incorporation of the haloderivative BrdU into
DNA, indicating marked differences in the ability to
distinguish modified dUTP from the non-modified
precursor. The most efficient incorporation was
obtained using Bst exo- DNA Polymerase.
vi. The presence of incorporated BrdU was proven
by both ligation assay and HPLC analysis.
vii. The BrdU incorporation study is a contribution
to the long-term goal of devising an anti-cancer
therapy based on the in vivo incorporation of a halo-
derivative, followed by treatment with ionizing
radiation.
Methods
Bacterial strains, media and reagents
Escherichia coli (E. coli)D H 1 1 S{ mcrA Δ[mrr-hsdRMS(rK-,
mK+)-mcrBC] Δ(lac-proAB) Δ(recA1398) deoR, rpsL, srl-
thi, supE/F’ proAB
+ lacI
QZΔM15} (Life Technologies,
Gaithersburg, MD, USA) was used as cloning host and for
Figure 5 Incorporation of double and single BrdU residues by
Bst exo
- DNA Polymerase into the 466 bp hybrid molecule.
Incorporation reactions using BrdUTP alone or in combination with
dTTP were carried out with Bst exo
- DNA Polymerase. Lanes M,
Perfect 100 bp Ladder (selected bands marked). Enzyme purity and
reaction steps controls: lane 1, uncut 437 bp PCR fragment
amplified from pGCN1 plasmid; lane 2, uncut 480 bp PCR fragment
amplified from pGCN2 plasmid; lane 3, BsaI-cut 437 bp fragment;
lane 4, BsaI-cut 480 bp fragment; lane 5, BsaI restriction fragment I
(191 bp) filled in with BrdUTP isolated from agarose gel; lane 6, BsaI
restriction fragment III (270 bp) filled in with BrdUTP isolated from
agarose gel; lane 7, BsaI-cut 437 bp fragment, purified and back-
ligated; lane 8, BsaI-cut 437 bp fragment, purified, incubated with
Bst exo- DNA Pol without dNTPs and back-ligated. Incorporation
reaction: lane 9, fragment I (191 bp) filled in with dTTP, ligated to
BrdU-labeled fragment III (270 bp); lane 10, fragment I (191 bp) filled
in with BrdUTP, ligated to BrdU-labeled fragment III (270 bp).
I, III
BsaI restriction fragments numbered as in Figure 1.
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[40] supplemented with chloramphenicol (40 μg/ml).
BrdUTP and dNTPs were from Sigma-Aldrich (St. Louis,
MO, USA). Difco media components were obtained from
Becton-Dickinson (Franklin Lakes, NJ, USA), agarose
GTG from FMC (Rockland, MA, USA), and the DNA pur-
ification kits, T4 DNA polymerase, Tfl DNA Polymerase,
Taq DNA Polymerase, OptiTaq, GeneMatrix PCR/DNA
Clean-Up Purification Kit and GeneMatrix Agarose-Out
DNA Purification Kit were from EURx Ltd. (Gdansk,
Poland). Bst DNA Polymerase large fragment exo-, pUC19
DNA, BsaI, NcoI and BspHI, T4 DNA ligase REase were
from New England Biolabs (Ipswich, MA, USA). Pfu DNA
Polymerase was from Agilent Technologies, Inc. (Santa
Clara, CA, USA). Oligo and custom DNA sequencing
were provided by Genomed (Warsaw, Poland). All other
reagents were from Amresco (Solon, OH, USA) or Sigma-
Aldrich, of the highest available purity.
Construction of DNA molecules with precisely
incorporated 5-BrdU
To validate the universality of the proposed method, we
used three different DNA constructs in vitro for the pin-
point incorporation of either double or single 5-BrdU.
Figure 6 Chromatograms of the mixture of standards (A) and BrdU-labeled 441 bp oligomer after enzymatic digestion (B).
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The 977 bp hybrid DNA molecule was generated from
two PCR products (379 bp and 625 bp) amplified from
the pUC19 plasmid template. The 378 bp fragment was
obtained using primer 1F: 5’-GTGGCGAAACCCGA-
CAGGACT-3’ and primer 1R:
5’-ATGAGTCATCCACCCATGAGACCACTTCAA-
GAACTC-3’, whereas the primer 2F: 5’-GGATGTGCT-
GCAAGGCGATTA-3’ and primer 2R:
5’-ATGAGTCATCCAGGGATGAGACCTCTGACTT-
GAGCG-3’ were used for the 625 bp fragment.
Incorporated BsaI sites are shown in bold and under-
lined. The hybrid molecule and PCR fragment sequences
are available as additional files (Additional file 1).
441 bp hybrid DNA molecule
The 441 bp hybrid DNA molecule was generated from
two PCR products (208 bp and 260 bp) amplified from
the pUC19 plasmid template. The 208 bp fragment was
obtained using primer 3F: 5’-AGCGGTATCAGCT-
CACTCAAAGG-3’ and primer 2R, whereas primer 4F:
5’- GAAGCGTGGCGCTTTCTCATAG -3’ and primer
1R were used for the 260 bp fragment. The hybrid
molecule and PCR fragment sequences are available as
additional files (Additional file 2).
The PCR reactions for generating 977 bp and 441 bp
molecules were conducted in 50 μlv o l u m e ,0 . 5m Mo f
each primer, template 2.5 ng, 60 μM dNTPs, 2.5 units
Taq Polymerase under thermocycling conditions: initial
denaturation at 97°C for 2.5 min, hot start at 80°C,
denaturation at 94°C for 30 sec, annealing at 53°C for
30 sec, extension at 72°C for 50 sec, final flush-in at 72°
C for 50 sec, 40 cycles. The amplification products were
purified using the PCR/DNA Clean-Up Purification Kit.
466 bp hybrid DNA molecule
The 466 bp hybrid DNA molecule was generated from
two PCR products (437 bp and 480 bp) amplified from
two plasmid pRZ4737-derivatives. The templates used
here (pGCN1 and pGNC2) were constructed by PCR
and cloning for the purpose of this work as well as
further studies on protein-directed Hal-NBs incorpora-
tion. The starting DNA for the construction was modi-
fied pRZ4737 plasmid vector (Cm
R, P15A ori, f1 ori,P R
promoter), originally obtained from Bill Resnikoff. Two
PCR fragments of 162 bp and 128 bp were amplified
from the vector using oligonucleotides containing long
5’- overhangs and incorporating class-IIS REase BsaI
and NcoI sites at each fragment 5’-end (forward pri-
mers) and BspHI (reverse primer). Incorporated REase
sites are shown in bold or underlined. The 162 bp frag-
ment was amplified with 5F primer: 5’-G C G CCATGG-
TCTCATCCCTGGATGACTCATTTCTTTTTTGTGC-
3’ and 3R primer: 5’-A G C TCATGAACACCTCCT-
TAAAAAAAAAATGAGTCATCCATTATCACCG-3’.
The 128 bp fragment was amplified with 6F primer:
5’-CTTCCATGGTCTCATGGGAAATCTATCACCGC-
A-3’and the 3R primer.
The 162 bp and 128 bp PCR products were cleaved
with NcoI and BspHI and cloned into pRZ4737-deriva-
tive cleaved with BspHI. The BspHI and NcoI sites have
compatible cohesive ends, which are not recleavable
after cross-ligation. For further experiments plasmids
were selected and designated pGCN1 and pGCN2. From
these, construct upstream primers were used to amplify
the 437 bp and 480 bp fragments for the labeling reac-
tion. Primer 7F: 5’- AATTACCTATTGACGCAAGTC-
TCGAAGGCGACGTGCGTCC-3’ w a su s e da sf o r w a r d
primer for the 437 bp product (template: pGCN1), and
primer 8F: 5’-CATTAAATAAAGCACCAACGCCT-3’
for the 480 bp product (template: pGCN2). Primer 4R:
5’-GAATTGTGAGCGGATAACAATTTCACACAG-3’
was used as reverse primer for both fragments. Hybrid
molecule and PCR fragment sequences are available as
additional files (Additional file 3). The PCR reactions for
the 437 bp and 480 bp fragments were conducted in 50
μl volume, 0.5 mM each primer, template 2.5 ng, 60 μM
dNTPs, 2.5 units Taq Polymerase under thermocycling
conditions: initial denaturation at 94.5°C for 1.5 min,
hot start at 80°C, denaturation at 94°C for 20 sec,
annealing at 58°C for 30 sec, extension at 72°C for 40
sec, final flush-in at 72°C for 50 sec, 40 cycles. Amplifi-
cation products were purified using the PCR/DNA
Clean-Up Purification Kit.
BrdU labeling reactions
Purified PCR products were cleaved with BsaI (10 units
per 1 μg/DNA) for 1 h at 50°C as recommended by the
manufacturer. Fill-in reactions were performed in 80 μl
reaction volume, containing 5 μg DNA, 40 units of poly-
merase, 0.2 mM BrdUTP, for 20 min at 70°C for ther-
mophilic polymerases and 37°C for mesophilic
polymerases in dedicated reaction buffers as recom-
mended by the manufacturer. Ligation was carried out
with 200 units of T4 DNA Ligase for 1.5 h at 16°C in
100 μl reaction volume in the buffer recommended by
the manufacturer.
HPLC detection of incorporated 5-BrdU
The purified DNA was digested to nucleosides prior to
HPLC analysis by the simultaneous action of DNase I,
snake venom phosphodiesterase (SVP) and bacterial
alkaline phosphatase (BAP). 40 units of DNase I, 1 unit
of BAP and 0.01 units of SVP were incubated with the
purified DNA fragment in a final volume of 100 μli n
the following reaction buffer: Tris-HCl (pH 8.5; 10
mM), MgCl2 (10 mM), CaCl2 (1 mM) and DTPA
(diethylenetriamine pentaacetic acid, Sigma Aldrich) (40
μM). The enzymatic digestion was performed at 37°C
for 3 h (1 h with each enzyme, sequentially). After
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tion using Microcon centrifugal filter units with a YM-3
membrane, NMWCO 3 kDa (Millipore). The resulting
samples were dried down by rotary evaporation in a
Speed-Vac Concentrator and dissolved in 60 μl of ultra-
pure water. 20 μl of the filtered sample was subjected to
HPLC analysis, which was performed on a Waters
®
600E Delivery System with a Waters
® 2487 Dual
Lambda Absorbance detector set at 260 nm for moni-
toring the effluents. A Waters
® Atlantis reverse-phase
dC18 column (4.6 × 150 mm; 5 μmi np a r t i c l es i z ea n d
100 L in pore size) with a mobile phase consisting of
deionized water, acetonitrile (Sigma-Aldrich, Poland)
and 1% formic acid (POCH S.A., Poland) (pH 2.55;
87.7:2:10.3, v/v/v) was used. The flow rate was set at 1
ml/min.
Additional material
Additional file 1: Sequence of the 977 hybrid DNA molecule. All
DNA sequences are written in the 5’-3’ direction. The DNA sequence of
the 379 bp PCR fragment is written in capital letters. The DNA sequence
of the 625 bp PCR fragment is written in small letters. The positions that
can be substituted with BrdU are marked in red and bold. The arrows
show the BsaI cleavage points. The BsaI recognition sequences are
placed in rectangular boxes. The BsaI restriction fragments forming the
hybrid molecule are underlined. The DNA fragments removed following
BsaI cleavage are in italics.
Additional file 2: Sequence of the 441 hybrid DNA molecule. All
DNA sequences are written in the 5’-3’ direction. The DNA sequence of
the 260 bp PCR fragment is written in capital letters. The DNA sequence
of the 208 bp PCR fragment is written in small letters. The positions that
can be substituted with BrdU are marked in red and bold. The arrows
show the BsaI cleavage points. The BsaI recognition sequences are
placed in rectangular boxes. The BsaI restriction fragments forming the
hybrid molecule are underlined. The DNA fragments removed following
BsaI cleavage are in italics.
Additional file 3: Sequence of the 446 hybrid DNA molecule. All
DNA sequences are written in the 5’-3’ direction. The DNA sequence of
the 437 bp PCR fragment is written in capital letters. The DNA sequence
of the 480 bp PCR fragment is written in small letters. The positions that
can be substituted with BrdU are marked in red and bold. The arrows
show the BsaI cleavage points. The BsaI recognition sequences are
placed in rectangular boxes. The BsaI restriction fragments forming the
hybrid molecule are underlined. The DNA fragments removed following
BsaI cleavage are in italics.
Acknowledgements
The authors would like to express their gratitude to Piotr Storoniak for his
valuable technical assistance. This work was supported by the Polish Ministry
of Science and Higher Education under Grants Nos. N N204 023135 (J.R) and
NR12-0070-06/2009 (P.S.).
Authors’ contributions
IS performed most of the experiments, participated in the preparation of the
figures and in the design and interpretation of all the experimental analyses.
KP performed some experiments and participated in the design and
interpretation of the experimental analyses. AŻS participated in the design
and interpretation of the experimental analyses, the preparation of the
figures and the writing of the manuscript. JJF prepared the cloned
templates. PMS came up with the concept of the new method of
nucleobase incorporation at a precisely pre-determined distance,
participated in the design and interpretation of experiments and drafted the
manuscript. JR participated in the design and interpretation of the
experiments, conceived the project, coordinated its execution and drafted
the manuscript. All authors read and approved the final manuscript.
Received: 31 March 2011 Accepted: 24 August 2011
Published: 24 August 2011
References
1. Szybalski W, Kim SC, Hasan N, Podhajska AJ: Class- IIS restriction enzymes–
a review. Gene 1991, 100:13-26, Erratum in: Gene 1991, 20, 109(1):169.
2. Kim SC, Podhajska AJ, Szybalski W: Cleaving DNA at any predetermined
site with adapter-primers and class-IIS restriction enzymes. Science 1988,
240(4851):504-506.
3. Kim SC, Skowron PM, Szybalski W: Structural requirements for FokI-DNA
interaction and oligodeoxyribonucleotide-instructed cleavage. J Mol Biol
1996, 258(4):638-649.
4. Koob M, Grimes E, Szybalski W: Conferring new specificity upon restriction
endonucleases by combining repressor-operator interaction and
methylation. Gene 1988, 74(1):165-167.
5. Skowron PM, Harasimowicz R, Rutkowska SM: GCN4 eukaryotic
transcription factor/FokI endonuclease mediated ‘Achilles’ Heel
Cleavage’: quantitative study of protein-DNA interaction. Gene 1996,
170:1-8.
6. Lee JH, Skowron PM, Rutkowska SM, Hong SS, Kim SC: Sequential
amplification of cloned DNA as tandem multimers using class-IIS
restriction endonucleases. Genet Anal 1996, 13:139-145.
7. Kim YG, Chandrasegaran S: Chimeric restriction endonuclease. Proc Natl
Acad Sci USA 1994, 91(3):883-887.
8. Sugiyama H, Fuijmoto K, Saito I: Preferential C1’ hydrogen abstraction by
an uracilyl radical in a DNA-RNA hybrid. Tetrahedron Lett 1997,
38(46):8057-8060.
9. Kawai K, Saito I, Sugiyama H: Conformation-dependent photochemistry of
5- halouracil-containing DNA: Stereospecific 2’-hydroxylation of
deoxyribose in Z-form DNA. J Am Chem Soc 1999, 121(6):1391-1392.
10. Oyoshi T, Wang AH-J, Sugiyama H: Photoreactivity of 5-iodouracil-
containing DNA-Sso7d complex in solution: the protein-induced DNA
kink causes intrastrand hydrogen abstraction from the 5-methyl of
thymine at the 5’ side. J Am Chem Soc 2002, 124(4):579-584.
11. Dietz TM, Koch TH: Photochemical reduction of 5-bromouracil by
cysteine derivatives and coupling of 5-bromouracil to cysteine
derivatives. Photochem Photobiol 1989, 49(2):121-129.
12. Blatter EE, Ebright YW, Ebright RH: Identification of an amino acid-base
contact in the GCN4-DNA complex by bromouracil-mediated
photocrosslinking. Nature 1992, 359(6396):650-652.
13. Willis MC, Hicke BJ, Uhlenbeck OC, Cech TR, Koch TH: Photocrosslinking of
5-iodouracil-substituted RNA and DNA to proteins. Science 1993,
262(5137):1255-1257.
14. Jansen KB, Atkinson BL, Willis MC, Koch TH, Gold L: Using in vitro selection
to direct the covalent attachment of human immunodeficiency virus
type 1 Rev protein to high-affinity RNA ligands. Proc Natl Acad Sci USA
1995, 92(26):12220-12224.
15. Beach C, Fuciarelli AF, Zimbrick JD: Electron migration along 5-
bromouracil-substituted DNA irradiated in solution and in cells. Radiat
Res 1994, 137(3):385-93.
16. Rivera E, Schuler RH: Intermediates in the reduction of 5-halouracils by
eaq =
-1. J Phys Chem 1983, 87(20):3966-3971.
17. Cecchini S, Girouard S, Huels MA, Sanche L, Hunting DJ: Interstrand cross-
links: a new type of gamma-ray damage in bromodeoxyuridine-
substituted DNA. Biochemistry 2005, 44(6):1932-1940.
18. Zeng Y, Wang Y: Facile formation of an intrastrand cross-link lesion
between cytosine and guanine upon pyrex-filtered UV light irradiation
of d((Br)CG) and duplex DNA containing 5-bromocytosine. J Am Chem
Soc 2004, 126(21):6552-6553.
19. Zhang Q, Wang Y: Generation of 5-(2’-deoxycytidyl)methyl radical and
the formation of intrastrand cross-link lesions in
oligodeoxyribonucleotides. Nucleic Acid Res 2005, 33(5):1593-1603.
20. Hong H, Wang Y: Formation of intrastrand cross-link products between
cytosine and adenine from UV irradiation of d((Br)CA) and duplex DNA
containing a 5-bromocytosine. J Am Chem Soc 2005, 127(40):13969-13977.
Sobolewski et al. BMC Biochemistry 2011, 12:47
http://www.biomedcentral.com/1471-2091/12/47
Page 11 of 1221. Fornace AJ Jr, Dobson PP, Kinsella TJ: Enhancement of radiation damage
in cellular DNA following unifilar substitution with iododeoxyuridine. Int
J Radiat Oncol Biol Phys 1990, 18(4):873-878.
22. Franken NA, Van Bree CV, Kipp JB, Barendsen GW: Modification of
potentially lethal damage in irradiated Chinese hamster V79 cells after
incorporation of halogenated pyrimidines. Int J Radiat Biol 1997,
72(1):101-109.
23. Watanabe T, Bando T, Xu Y, Tashiro R, Sugiyama H: Efficient generation of
2’-deoxyuridin-5-yl at 5’-(G/C)AA(X)U(X)U-3’ (X = Br, I) sequences in
duplex DNA under UV irradiation. J Am Chem Soc 2005, 127(1):44-45.
24. Fujimoto K, Ikeda Y, Saito I: Direct strand cleavage via furanyladenine
formation in anaerobic photoirradiation of 5-bromouracil-containing
oligonucleotides. Tetrahedron Lett 2000, 41(33):6455-6459.
25. Cook GP, Greenberg MM: A Novel Mechanism for the Formation of Direct
Strand Breaks upon Anaerobic Photolysis of Duplex DNA Containing 5-
Bromodeoxyuridine. J Am Chem Soc 1996, 118(42):10025-10030.
26. Cook GP, Chen T, Koppisch AT, Greenberg MM: The effects of secondary
structure and O2 on the formation of direct strand breaks upon UV
irradiation of 5-bromodeoxyuridine-containing oligonucleotides. Chem
Biol 1999, 6(7):451-459.
27. Sugiyama H, Tsutsumi Y, Saito I: Highly sequence-selective photoreaction
of 5-bromouracil-containing deoxyhexanucleotides. J Am Chem So 1990,
112(18):6720-6721.
28. Fuijmoto K, Sugiyjama H, Saito I: Sequence dependent photoreduction of
5-bromouracil-contaning oligonucleotides via electron transfer.
Tetrahedron Lett 1998, 39(15):2137-2140.
29. Chen T, Cook GP, Koppisch AT, Greenberg MM: Investigation of the origin
of the sequence selectivityfor the 5-halo-2’-deoxyuridine sensitization of
DANN to damage by UV-irradiation. J Am Chem Soc 2000, 122:3861-3866.
30. Szybalski W: X-ray sensitization by halopyrimidines. Cancer Chemoter Rep
1974, 58(4):539-557.
31. Ling LL, Ward JF: Radiosensitization of Chinese hamster V79 cells by
bromodeoxyuridine substitution of thymidine: enhancement of
radiation-induced toxicity and DNA strand break production by
monofilar and bifilar substitution. Radiat Res 1990, 121(1):76-83.
32. Prados MD, Scott C, Sandler H, Buckner JC, Phillips T, Schultz C, Urtasun R,
Davis R, Guttin P, Cascino TL, Greenberg HS, Curran WJ: A phase 3
randomized study of radiotherapy plus procarbazine, CCNU, and
vincristine (PCV) with or without BUdR for the treatment of anaplastic
astrocytoma: a preliminary report of RTOG 9404. Int J Radiat Oncol Biol
Phys 1999, 5(5):1109-1115.
33. Erikson RL, Szybalski W: Molecular radiobiology of human cell lines. v.
comparative radiosensitizing properties of 5-halodeoxycytidines and 5-
halodeoxyuridines. Radiat Res 1963, 20:252-262.
34. Frenken NA, Van Bree C, Veltmaat MA, Rodermond HM, Haveman J,
Barensen GW: Radiosensitization by bromodeoxyuridine and
hyperthermia: analysis of linear and quadratic parameters of radiation
survival curves of two human tumor cell lines. J Radiat Res (Tokyo) 2001,
42(2):179-190.
35. Matsutani M, Kohno T, Nagashima T, Nagayama I, Matsuda T, Hoshino T,
Sano K: Clinical trial of intravenous infusion of bromodeoxyuridine
(BUdR) for radiosensitization of malignant brain tumors. Radiat Med 1988,
6(1):33-39.
36. Peters JP, Becker NA, Rueter EM, Bajzer Z, Kahn JD, Maher LJ: Quantitative
methods for measuring DNA flexibility in vitro and in vivo. 3rd Methods
Enzymol 2011, 488:287-335.
37. Roberts RJ, Vincze T, Posfai J, Macelis D: REBASE - enzymes and genes for
DNA restriction and modification. Nucleic Acids Res 2010, 38:D234-D236.
38. Pósfai G, Szybalski W: Increasing the Fokl cleavage specificity from 5 to 7
base pairs by two-step methylation. Nucleic Acids Res 1988, 16(13):6245.
39. Fogg MJ, Pearl LH, Connolly BA: Structural basis for uracil recognition by
archaeal family B DNA polymerases. Nat Struct Biol 2002, 9(12):922-927.
40. Sambrook J, Fitsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual
Cold Spring Harbor, Cold Spring Harbor Press; 1989.
doi:10.1186/1471-2091-12-47
Cite this article as: Sobolewski et al.: Enzymatic synthesis of long
double-stranded DNA labeled with haloderivatives of nucleobases in a
precisely pre-determined sequence. BMC Biochemistry 2011 12:47.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Sobolewski et al. BMC Biochemistry 2011, 12:47
http://www.biomedcentral.com/1471-2091/12/47
Page 12 of 12